A detailed history of State Street Corp transactions in Journey Medical Corp stock. As of the latest transaction made, State Street Corp holds 28,953 shares of DERM stock, worth $144,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,953
Previous 25,553 13.31%
Holding current value
$144,185
Previous $144,000 18.75%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.97 - $6.53 $13,498 - $22,202
3,400 Added 13.31%
28,953 $117,000
Q4 2023

Feb 14, 2024

BUY
$2.7 - $7.96 $36,990 - $109,052
13,700 Added 115.58%
25,553 $147,000
Q3 2023

Nov 14, 2023

BUY
$1.66 - $2.97 $19,675 - $35,203
11,853 New
11,853 $32,000

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $57.8M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.